Neoplasm Progression
36 drugs28,052 FAERS reportsMedDRA PT
GET
/api/v1/reaction/neoplasm-progressionReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Neoplasm Progression (36)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Dordaviprone512%
- 2Palbociclib10,62011%
- 3Dacomitinib7811%
- 4Talazoparib17110%
- 5Lorlatinib6249.6%
- 6Crizotinib1,1128.9%
- 7Axitinib1,3236.9%
- 8Fulvestrant2,1286.6%
- 9Glasdegib286.0%
- 10Encorafenib5525.8%
- 11Inotuzumab Ozogamicin1555.4%
- 12Ripretinib2665.3%
- 13Ziftomenib15.3%
- 14Binimetinib3945.2%
- 15Sunitinib2,0195.2%
- 16Malate2,0194.9%
- 17Pentetreotide64.7%
- 18Letrozole2,7964.6%
- 19Exemestane9244.4%
- 20Indium64.1%
- 21Ponatinib1973.8%
- 22Tucatinib2523.8%
- 23Elranatamab283.2%
- 24Avelumab1253.2%
- 25Irinotecan3783.1%
- 26Ceritinib662.8%
- 27Topotecan1782.6%
- 28Temsirolimus1102.4%
- 29Selumetinib322.3%
- 30Tafasitamab202.3%
- 31Epirubicin1412.3%
- 32Vincristine6492.3%
- 33Tebentafusp122.2%
- 34Temozolomide4402.1%
- 35Adagrasib171.7%
- 36Brigatinib180—
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Malignant Neoplasm Progression22 shared · 0.13
- Disease Progression28 shared · 0.12
- Stomatitis8 shared · 0.09
- Palmar-plantar Erythrodysaesthesia Syndrome4 shared · 0.08
- White Blood Cell Count Decreased9 shared · 0.08
- Haematotoxicity3 shared · 0.08
- Non-small Cell Lung Cancer3 shared · 0.08
- Lung Neoplasm Malignant3 shared · 0.07
- Platelet Count Decreased12 shared · 0.07
- Breast Cancer Metastatic3 shared · 0.07
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.